EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug
The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple sclerosis drug and for disparaging a rival company’s development of a competing me...
https://abcnews.go.com/International/wireStory/eu-commission-fines-teva-500-million-stop-rivals-115349141